BRVE Conversion Disclosure
Orbimed Advisors Llc · SEC Form 4 · Filed Aug 11, 2026
Conversion
Reported value range
Not reported
Orbimed Advisors Llc Director / Ten Percent Owner
BRVE
Braveheart Bio, Inc.
BRVE
Transaction date
Aug 7, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 4 days later
BRVE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,132,420 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0000947871-26-000782
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$34.92M
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Braveheart Bio, Inc. BRVE Current | Conversion | Aug 7, 2026 | Not reported |
| Braveheart Bio, Inc. BRVE | Buy | Aug 7, 2026 | $30M |
| Braveheart Bio, Inc. BRVE | Buy | Aug 7, 2026 | $4.92M |
| Braveheart Bio, Inc. BRVE | Conversion | Aug 7, 2026 | $0 |